← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
  1. Home
  2. PTN
  3. P/E History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

PTN logoPalatin Technologies, Inc. (PTN) P/E Ratio History

Historical price-to-earnings valuation from 2010 to 2020

Current P/E
-0.6
Undervalued
5Y Avg P/E
40.9
-101% vs avg
PE Percentile
0%
Low
PEG Ratio
N/A
N/A
TTM EPS$-8.76
Price$18.90
5Y PE Range2.6 - 382.5
Earnings YieldN/A

Loading P/E history...

PTN Valuation Context

How does the current P/E compare to historical and market benchmarks?

vs. 5Y Average
-0.6vs40.9
-101%
Cheap vs History
vs. Healthcare
-0.6vs22.3
-103%
Below Sector
vs. S&P 500
-0.6vs25.1
-102%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -1492% EPS growth (1Y)
Export Data

P/E Ratio Analysis

As of May 8, 2026, Palatin Technologies, Inc. (PTN) trades at a price-to-earnings ratio of -0.6x, with a stock price of $18.90 and trailing twelve-month earnings per share of $-8.76.

The current P/E is 101% below its 5-year average of 40.9x. Over the past five years, PTN's P/E has ranged from a low of 2.6x to a high of 382.5x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.3x, PTN trades at a 103% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.

Relative to the broader market, PTN trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PTN DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

PTN P/E vs Peers

P/E ratio compared to closely matched public peers

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
ANIP logoANIPANI Pharmaceuticals, Inc.
$2B25.3-+419%
HIMS logoHIMSHims & Hers Health, Inc.
$7B50.3--4%
INVA logoINVAInnoviva, Inc.
$2B6.9Lowest0.67+817%Best
ABBV logoABBVAbbVie Inc.
$358B85.5--1%
PFE logoPFEPfizer Inc.
$151B19.5--4%
LLY logoLLYEli Lilly and Company
$921B42.51.47+96%
IQV logoIQVIQVIA Holdings Inc.
$30B22.80.56Best+5%

Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.

PTN Historical P/E Data (2010–2020)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterDatePriceTTM EPSP/E Ratiovs Avg
FY2020 Q3$10.50$3.992.6x-94%
FY2020 Q2$19.50$3.875.0x-88%
FY2020 Q1Mon Sep 30 2019 00:00:00 GM$22.75$3.826.0x-85%
FY2019 Q4Sun Jun 30 2019 00:00:00 GM$29.00$3.618.0x-80%
FY2019 Q2Mon Dec 31 2018 00:00:00 GM$17.75$0.05382.5x+836%
FY2019 Q1Sun Sep 30 2018 00:00:00 GM$25.00$1.0324.4x-40%
FY2018 Q4Sat Jun 30 2018 00:00:00 GM$24.25$2.978.2x-80%
FY2018 Q3Sat Mar 31 2018 00:00:00 GM$27.25$3.228.5x-79%
FY2018 Q2Sun Dec 31 2017 00:00:00 GM$21.50$2.867.5x-82%
FY2018 Q1Sat Sep 30 2017 00:00:00 GM$16.50$1.0815.3x-63%
FY2010 Q3Wed Mar 31 2010 00:00:00 GM$65.00$4.7913.6x-67%
FY2010 Q2$92.50$10.209.1x-78%

Average P/E for displayed period: 40.9x

See PTN's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is PTN Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare PTN vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

PTN — Frequently Asked Questions

Quick answers to the most common questions about buying PTN stock.

Is PTN stock overvalued or undervalued?

PTN trades at -0.6x P/E, below its 5-year average of 40.9x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.

How does PTN's valuation compare to peers?

Palatin Technologies, Inc. P/E of -0.6x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.

What is PTN's PEG ratio?

PTN PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2010-2020.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

PTN P/E Ratio History (2010–2020)

P/E ratio calculated as closing price divided by trailing 12-month diluted EPS at each quarter end.